Cell cycle and cell size regulation in Down Syndrome cells
Although the neuropathological features typical for Down Syndrome obviously result from deregulation of both, cell cycle control and differentiation processes, so far research focused on the latter. Considering the known similarities between the neuropathology of Down Syndrome and Alzheimer’s disease and the knowledge, that in Alzheimer’s disease neuronal degeneration is associated with the activation of mitogenic signals and cell cycle activation, it is tempting to investigate the consequences of an additional chromosome 21 on mammalian cell cycle regulation. We analysed the distribution of cells in different cell cycle phases on the flowcytometer and the cell size of human amniotic fluid cells with normal karyotypes and with trisomy 21. We could not detect any significant differences suggesting that the presence of an additional copy of the about 225 genes on human chromosome 21 does not trigger cell cycle effects in amniotic fluid cells. These data provide new insights into the cell biology of trisomy 21 cells.
KeywordsDown Syndrome Cell Cycle Control Cell Cycle Phase Additional Chromosome Cell Cycle Activation
Unable to display preview. Download preview PDF.
- Arendt T (2002) Dysregulation of neuronal differentiation and cell cycle control in Alzheimer’s disease. J Neural Transm [Suppl] 62: 77–85Google Scholar
- Cairns NJ (1999) Neuropathology. J Neural Transm [Suppl] 57: 61–74Google Scholar
- Kligman D, Hilt CD (1988) The S100 protein family. Trends Biochem Sci 13: 437–443 Lubec G, Engidawork E (2002) The brain in Down syndrome (TRISOMY 21). J Neurol 249: 1347–1356Google Scholar
- Nurse P (1975) Genetic control of cell size at cell division in yeast. Nature 256: 547–551 Pardee AB (1974) A restriction point for control of normal animal proliferation. Proc Natl Acad Sci USA 71: 1286–1290Google Scholar
- Prusa A-R, Hengstschläger M (2002) Amniotic fluid cells and human stem cell research — a new connection. Med Sci Monit 8: 253–257Google Scholar
- Wegner R-D (1999) Diagnostic cytogenetics. Springer, Berlin Heidelberg New York TokyoGoogle Scholar